QT
FATE icon

Quantbot Technologies’s Fate Therapeutics FATE Stock Holding History

Quantbot Technologies’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,500
Closed -$101K – 1700
2023
Q3 		$101K Buy
47,500
+38,200
+411% +$127K 0.01% 1096
2023
Q2 		$44.3K Buy
9,300
+9,100
+4,550% +$50.2K ﹤0.01% 1331
2023
Q1 		$1.14K Sell
200
-26,900
-99% -$162K ﹤0.01% 1473
2022
Q4 		$273K Buy
27,100
+24,000
+774% +$451K 0.02% 784
2022
Q3 		$69K Buy
+3,100
New +$89.6K 0.01% 1186
2021
Q4 		– Sell
-10,818
Closed -$641K – 1643
2021
Q3 		$641K Buy
10,818
+10,482
+3,120% +$822K 0.05% 516
2021
Q2 		$29K Buy
336
+144
+75% +$11.6K ﹤0.01% 1168
2021
Q1 		$15K Buy
192
+21
+12% +$2.01K ﹤0.01% 1204
2020
Q4 		$15K Sell
171
-714
-81% -$44.3K ﹤0.01% 1050
2020
Q3 		$35K Buy
+885
New +$30.9K ﹤0.01% 916
2020
Q1 		– Sell
-3,700
Closed -$72K – 1049
2019
Q4 		$72K Buy
3,700
+3,400
+1,133% +$54K 0.01% 893
2019
Q3 		$4K Buy
+300
New +$5.75K ﹤0.01% 1211
2018
Q3 		– Sell
-74
Closed – – 1335
2018
Q2 		$0 Sell
74
-10,910
-99% -$120K ﹤0.01% 1287
2018
Q1 		$107K Buy
+10,984
New +$105K 0.01% 828

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quantbot Technologies's FATE Position: Q4 2023 in Review

Quantbot Technologies sold out of Fate Therapeutics (FATE) in Q4 2023, closing a stake of 47,500 shares — an estimated $101K sold.

Quantbot Technologies first reported a position in FATE in Q1 2018 and held it in 14 quarters. The position peaked at $641K in Q3 2021. 159 funds tracked by Wall St. Rank hold FATE as of Q4 2023.

  • Quantbot Technologies reported no remaining Fate Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 47,500 Fate Therapeutics shares in Q4 2023, an estimated $101K.
  • Quantbot Technologies first reported a position in Fate Therapeutics in Q1 2018 and held it in 14 quarters.
  • Quantbot Technologies's Fate Therapeutics position peaked at $641K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.